Detecting and Assessing Macrophages in Vivo to Evaluate Atherosclerosis Noninvasively Using Molecular MRI

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2007 Jan 12

PMID 17215360

Citations 146

Authors

Vardan Amirbekian

Michael J Lipinski

Karen C Briley-Saebo

Smbat Amirbekian

Juan Gilberto S Aguinaldo

David B Weinreb

Esad Vucic

Juan C Frias

Fabien Hyafil

Venkatesh Mani

Edward A Fisher

Zahi A Fayad

Affiliations

Soon will be listed here.

Abstract

We investigated the ability of targeted immunomicelles to detect and assess macrophages in atherosclerotic plaque using MRI in vivo. There is a large clinical need for a noninvasive tool to assess atherosclerosis from a molecular and cellular standpoint. Macrophages play a central role in atherosclerosis and are associated with plaques vulnerable to rupture. Therefore, macrophage scavenger receptor (MSR) was chosen as a target for molecular MRI. MSR-targeted immunomicelles, micelles, and gadolinium-diethyltriaminepentaacetic acid (DTPA) were tested in ApoE-/- and WT mice by using in vivo MRI. Confocal laser-scanning microscopy colocalization, macrophage immunostaining and MRI correlation, competitive inhibition, and various other analyses were performed. In vivo MRI revealed that at 24 h postinjection, immunomicelles provided a 79% increase in signal intensity of atherosclerotic aortas in ApoE-/- mice compared with only 34% using untargeted micelles and no enhancement using gadolinium-DTPA. Confocal laser-scanning microscopy revealed colocalization between fluorescent immunomicelles and macrophages in plaques. There was a strong correlation between macrophage content in atherosclerotic plaques and the matched in vivo MRI results as measured by the percent normalized enhancement ratio. Monoclonal antibodies to MSR were able to significantly hinder immunomicelles from providing contrast enhancement of atherosclerotic vessels in vivo. Immunomicelles provided excellent validated in vivo enhancement of atherosclerotic plaques. The enhancement seen is related to the macrophage content of the atherosclerotic vessel areas imaged. Immunomicelles may aid in the detection of high macrophage content associated with plaques vulnerable to rupture.

Citing Articles

Effective treatment of intractable diseases using nanoparticles to interfere with vascular supply and angiogenic process.

Hoseinzadeh A, Ghoddusi Johari H, Anbardar M, Tayebi L, Vafa E, Abbasi M Eur J Med Res. 2022; 27(1):232.

PMID: 36333816 PMC: 9636835. DOI: 10.1186/s40001-022-00833-6.

Advanced targeted nanomedicines for vulnerable atherosclerosis plaque imaging and their potential clinical implications.

Li X, Wu M, Li J, Guo Q, Zhao Y, Zhang X Front Pharmacol. 2022; 13:906512.

PMID: 36313319 PMC: 9606597. DOI: 10.3389/fphar.2022.906512.

Emerging Nuclear Medicine Imaging of Atherosclerotic Plaque Formation.

Kondakov A, Berdalin A, Beregov M, Lelyuk V J Imaging. 2022; 8(10).

PMID: 36286355 PMC: 9605050. DOI: 10.3390/jimaging8100261.

Recent advances in targeted delivery of non-coding RNA-based therapeutics for atherosclerosis.

Li X, Qi H, Cui W, Wang Z, Fu X, Li T Mol Ther. 2022; 30(10):3118-3132.

PMID: 35918894 PMC: 9552813. DOI: 10.1016/j.ymthe.2022.07.018.

Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis.

Chen W, Schilperoort M, Cao Y, Shi J, Tabas I, Tao W Nat Rev Cardiol. 2021; 19(4):228-249.

PMID: 34759324 PMC: 8580169. DOI: 10.1038/s41569-021-00629-x.

References

Ruehm S, Corot C, Vogt P, Kolb S, Debatin J . Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation. 2001; 103(3):415-22. DOI: 10.1161/01.cir.103.3.415. View

Rabinowitz S, Gordon S . Macrosialin, a macrophage-restricted membrane sialoprotein differentially glycosylated in response to inflammatory stimuli. J Exp Med. 1991; 174(4):827-36. PMC: 2118958. DOI: 10.1084/jem.174.4.827. View

Yancy A, Olzinski A, Hu T, Lenhard S, Aravindhan K, Gruver S . Differential uptake of ferumoxtran-10 and ferumoxytol, ultrasmall superparamagnetic iron oxide contrast agents in rabbit: critical determinants of atherosclerotic plaque labeling. J Magn Reson Imaging. 2005; 21(4):432-42. DOI: 10.1002/jmri.20283. View

Fayad Z, Fallon J, Shinnar M, Wehrli S, Dansky H, Poon M . Noninvasive In vivo high-resolution magnetic resonance imaging of atherosclerotic lesions in genetically engineered mice. Circulation. 1998; 98(15):1541-7. DOI: 10.1161/01.cir.98.15.1541. View

Kelly K, Allport J, Tsourkas A, Shinde-Patil V, Josephson L, Weissleder R . Detection of vascular adhesion molecule-1 expression using a novel multimodal nanoparticle. Circ Res. 2005; 96(3):327-36. DOI: 10.1161/01.RES.0000155722.17881.dd. View

Gustafsson B, Youens S, Louie A . Development of contrast agents targeted to macrophage scavenger receptors for MRI of vascular inflammation. Bioconjug Chem. 2006; 17(2):538-47. PMC: 2556229. DOI: 10.1021/bc060018k. View

Winter P, Morawski A, Caruthers S, Fuhrhop R, Zhang H, Williams T . Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles. Circulation. 2003; 108(18):2270-4. DOI: 10.1161/01.CIR.0000093185.16083.95. View

Murray C, Lopez A . Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet. 1997; 349(9063):1436-42. DOI: 10.1016/S0140-6736(96)07495-8. View

Goldstein J, Ho Y, Basu S, Brown M . Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci U S A. 1979; 76(1):333-7. PMC: 382933. DOI: 10.1073/pnas.76.1.333. View

10.

Krieger M, Herz J . Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu Rev Biochem. 1994; 63:601-37. DOI: 10.1146/annurev.bi.63.070194.003125. View

11.

Hansson G . Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005; 352(16):1685-95. DOI: 10.1056/NEJMra043430. View

12.

Hyafil F, Laissy J, Mazighi M, Tchetche D, Louedec L, Adle-Biassette H . Ferumoxtran-10-enhanced MRI of the hypercholesterolemic rabbit aorta: relationship between signal loss and macrophage infiltration. Arterioscler Thromb Vasc Biol. 2005; 26(1):176-81. DOI: 10.1161/01.ATV.0000194098.82677.57. View

13.

Zheng Z, Croft J, Giles W, Mensah G . Sudden cardiac death in the United States, 1989 to 1998. Circulation. 2001; 104(18):2158-63. DOI: 10.1161/hc4301.098254. View

14.

Meir K, Leitersdorf E . Atherosclerosis in the apolipoprotein-E-deficient mouse: a decade of progress. Arterioscler Thromb Vasc Biol. 2004; 24(6):1006-14. DOI: 10.1161/01.ATV.0000128849.12617.f4. View

15.

Suzuki H, Kurihara Y, Takeya M, Kamada N, Kataoka M, Jishage K . A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature. 1997; 386(6622):292-6. DOI: 10.1038/386292a0. View

16.

Lipinski M, Amirbekian V, Frias J, Aguinaldo J, Mani V, Briley-Saebo K . MRI to detect atherosclerosis with gadolinium-containing immunomicelles targeting the macrophage scavenger receptor. Magn Reson Med. 2006; 56(3):601-10. DOI: 10.1002/mrm.20995. View

17.

de Winther M, van Dijk K, Havekes L, Hofker M . Macrophage scavenger receptor class A: A multifunctional receptor in atherosclerosis. Arterioscler Thromb Vasc Biol. 2000; 20(2):290-7. DOI: 10.1161/01.atv.20.2.290. View

18.

Plump A, Smith J, Hayek T, Aalto-Setala K, Walsh A, Verstuyft J . Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 1992; 71(2):343-53. DOI: 10.1016/0092-8674(92)90362-g. View

19.

Piedrahita J, Zhang S, Hagaman J, Oliver P, Maeda N . Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc Natl Acad Sci U S A. 1992; 89(10):4471-5. PMC: 49104. DOI: 10.1073/pnas.89.10.4471. View

20.

Smith J, Trogan E, Ginsberg M, Grigaux C, Tian J, Miyata M . Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. Proc Natl Acad Sci U S A. 1995; 92(18):8264-8. PMC: 41137. DOI: 10.1073/pnas.92.18.8264. View